Ixazomib (Ninlaro)
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Ixazomib (Ninlaro), covering 2024-06-21 to 2026-04-15. Get the full timeline:
Most recent: Clinical Trial Update: Daratumumab, Bortezomib, and Dexamethasone Followed by Daratumumab, Ixazomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma [Phase 2]